Treatments for attention-deficit/hyperactivity disorder
73 results
1 - 73
Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders- Stimulant and non‐stimulant drug therapy for people with attention deficit hyperactivity disorder and epilepsy
- Family therapy for attention‐deficit disorder or attention‐deficit/hyperactivity disorder in children and adolescents
- Meditation therapies for attention‐deficit/hyperactivity disorder (ADHD)
- Homeopathy for attention deficit/hyperactivity disorder or hyperkinetic disorder
- Parent training interventions for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years: Cochrane systematic review
- Amfetamine for attention deficit hyperactivity disorder in people with intellectual disabilities
- Risperidone for attention‐deficit hyperactivity disorder in people with intellectual disabilities
- Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescents
- Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults
- Acupuncture for Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents: Cochrane systematic review
- Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults: Cochrane systematic review
- Social skills training for attention deficit hyperactivity disorder (ADHD) in children aged 5 to 18 years
- Cognitive‐behavioural interventions for attention deficit hyperactivity disorder (ADHD) in adults
- Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents
- Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)
- Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents – assessment of adverse events in non-randomised studies: Cochrane systematic review
- Bupropion for attention deficit hyperactivity disorder (ADHD) in adults
- Extended‐release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults
- Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents: Cochrane systematic review
- Immediate‐release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults
- Methylphenidate for children and adolescents with autism spectrum disorder
- Polyunsaturated fatty acids (PUFAs) for children with specific learning disorders
- L‐acetylcarnitine for treating fragile X syndrome
- Memantine for autism spectrum disorder
- Pharmacological intervention for irritability, aggression, and self‐injury in autism spectrum disorder (ASD)
- Pine bark (Pinus spp.) extract for treating chronic disorders
- Interventions for pathological gambling: Cochrane systematic review
- Statins for Smith‐Lemli‐Opitz syndrome
- New generation antidepressants for depression in children and adolescents: a network meta‐analysis
- Effect of amphetamines on blood pressure
- Personalised interventions for subgroups of children with conduct problems
- Pharmacological interventions for those who have sexually offended or are at risk of offending
- Education support services for improving school engagement and academic performance of children and adolescents with a chronic health condition
- Sedation of children undergoing dental treatment